Endo Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 356.6 | 365.7 | 345.3 |
| Net Investing Cash Flow | 178.8 | (614.5) | (66.4) |
| Net Financing Cash Flow | (110.1) | (29.0) | (151.8) |
| Net Change in Cash | 425.4 | (277.8) | 127.1 |
| Depreciation & Amortization | 46.4 | 17.4 | 17.5 |
| Capital Expenditures | (17.4) | (20.0) | (13.2) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
